This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Total Voting Rights
3rd June 2013
In conformity with the FSA’s Disclosure and Transparency Rules, Cello Group plc (“Cello” or the “Company”) confirms the following:
As at the close of business on 30 May 2013 Cello’s issued share capital consisted of 82,683,959 ordinary shares of 10 pence each (“Ordinary Shares”), all with voting rights. The Company holds 237,000 Ordinary Shares in treasury. The total number of current voting rights in the Company will therefore be 82,446,959 shares.
The above figure (82,446,959 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FSA’s Disclosure and Transparency Rules.
Enquiries:
| Cello Group | 020 7812 8460 |
| Mark Scott, Chief Executive | |
| Mark Bentley, Finance Director | |
| Cenkos Securities | 0207 397 8900 |
| Bobbie Hilliam | |
| Buchanan | |
| Mark Edwards/ Nicola Cronk/ Clare Akhurst | 020 7466 5000 |
Contact Us
Address
Cello Health plc
Queens House
8-9 Queen Street
London
EC4N 1SP
Registered Office
Queens House
8-9 Queen Street
London
EC4N 1SP
Company Registered
in England no.05120150